CTLA-4 is a member of the immunoglobulin superfamily; after T cell activation, CTLA-4 is expressed on the plasma membrane of cells where it acts to inhibit T cell function through a variety of mechanisms, allowing tumor cells to escape immune surveillance (69, 70). The gene discussed is CTLA4; the disease is neoplasm.